Opiant Pharmaceuticals In... (OPNT)
NASDAQ: OPNT
· Real-Time Price · USD
20.65
0.00 (0.00%)
At close: Mar 01, 2023, 10:00 PM
Opiant Pharmaceuticals Revenue
Opiant Pharmaceuticals reported an annual revenue of $40.73M, reflecting a 48.62% growth. For the quarter ending September 30, 2022, Opiant Pharmaceuticals generated $173.87M in revenue.
Revenue (ttm)
40.73M
Revenue Growth
48.62%
Price / Sales Ratio
3.68
Revenue / Employee
1.1M
Employees
37
Market Cap
108.8M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2021 | 40.73M | +48.62% |
| Dec 31, 2020 | 27.4M | -28.33% |
| Dec 31, 2019 | 38.24M | +182.96% |
| Dec 31, 2018 | 13.51M | -26.74% |
| Jul 31, 2017 | 18.45M | +86.36% |
| Jul 31, 2016 | 9.9M | +538.58% |
| Jul 31, 2015 | 1.55M | +Infinity% |
| Jul 31, 2014 | 0 | n/a |
| Jul 31, 2013 | 0 | n/a |
| Jul 31, 2012 | 0 | n/a |
| Jul 31, 2011 | 0 | n/a |
| Jul 31, 2010 | 0 | n/a |
| Jul 31, 2009 | 0 | n/a |
| Jul 31, 2008 | 0 | n/a |
| Jul 31, 2007 | 0 | n/a |